Medicare for all

Medicare for All is a proposal to replace most private health insurance in the United States with one national public plan. Everyone would be covered automatically. Premiums, deductibles, and copays for covered care would largely disappear. Taxes and redirected public spending would take their place. Private insurers could sell only supplemental policies that do not duplicate the public benefit.

That is the core of the bills Sen. Bernie Sanders and Rep. Pramila Jayapal have reintroduced in the current Congress—S. 1506 and H.R. 3069. It is not an expansion of today’s Medicare for people over 65. It is a new national insurance program that uses the Medicare name, absorbs Medicare and most of Medicaid, and shuts down the ACA marketplaces and employer plans as primary coverage.

The slogan is more popular than the statute. Polls often find majority support for “Medicare for All” or a national government plan. The same surveys show many respondents believe they could keep employer coverage, and support falls when the question includes higher taxes or the end of private insurance. That gap between brand and bill is the first thing to understand.

What the bills would do

Under the leading House and Senate versions, every U.S. resident would be entitled to a broad package of benefits: hospital and physician care, prescription drugs, mental health and substance-use treatment, dental and vision, reproductive care, and long-term care. Cost-sharing for covered services would be prohibited. Enrollment would be automatic at birth or upon residency. Veterans Affairs and Indian Health Service coverage would remain. Almost everything else that now functions as primary insurance would end.

The transition is short by historical standards. The House bill contemplates full implementation two years after enactment, with earlier enrollment for children, people 55 and older, and current Medicare beneficiaries, plus a temporary buy-in for everyone else. During that window, people could keep existing coverage. After it, duplicative private insurance would be illegal.

Providers would be paid by the new program under rules set by HHS. Drug prices would be negotiated. The current maze of Medicare, Medicaid, CHIP, ACA subsidies, and most employer tax exclusions would be folded into one budget. That consolidation is the source of both the promised administrative savings and the political fight.

As of mid-to-late 2026 the House bill had more than 100 Democratic cosponsors—roughly half the caucus. The Senate bill had 17. Neither has received a committee markup. Sponsors describe the near term as groundwork for a future governing trifecta, not a bill that can pass with divided government.

How this differs from the system Americans already have

The United States already has large single-payer programs. Traditional Medicare is a national insurer for older and disabled people. Medicaid is a joint federal-state insurer for low-income people. Together with CHIP, the VA, and other public programs, government already finances a large share of national health spending.

Medicare for All would extend that logic to the entire population and, in the standard bills, make it nearly the only primary payer. That is a different claim from “build on the ACA,” a public option, or “Medicare for All Who Want It,” which leave private insurance intact and let people opt in.

The distinction matters for households. About 166 million people under 65 have employer-sponsored insurance. Those plans would cease as comprehensive coverage. Workers would no longer see a premium deducted from a paycheck. They would see new taxes instead, and employers would stop buying group policies. Whether a given family came out ahead would depend on the tax design, the value of the new benefit package, and how much they now pay in premiums and out-of-pocket costs.

The cost debate, stated carefully

There are two different cost questions, and they get collapsed in slogans.

How much would the federal government spend? A lot more. The Congressional Budget Office’s illustrative single-payer options, built around a Medicare-like fee-for-service program, found that federal health subsidies in 2030 would rise by about $1.5 trillion to $3.0 trillion a year relative to current law. That is the cost of the government picking up bills now paid by employers, households, and states.

How much would the country spend in total? That can go down or up. In the same CBO analysis, national health expenditures in 2030 ranged from a $700 billion decrease to a $300 billion increase, depending on provider payment rates, cost-sharing, and whether long-term care was included. Lower prices and lower insurer overhead pull spending down. Zero cost-sharing and a richer benefit package pull utilization—and spending—up.

Those ranges are not a verdict that the idea “saves money” or “blows the budget.” They are a statement that design is the policy. Pay hospitals at current Medicare rates, ban cost-sharing, and add long-term care, and you get one fiscal world. Pay closer to commercial rates, keep modest cost-sharing, and leave long-term care aside, and you get another.

CBO also flagged a supply problem. If demand for care rises because it is free at the point of service, and if prices paid to doctors and hospitals fall, the extra demand may not all be met. The result would be queues, delayed appointments, or implicit rationing rather than an unlimited increase in services. How large that gap would be is one of the most contested points in the literature. Optimistic analyses assume large administrative-time savings for clinicians and a flexible supply response. Pessimistic analyses assume the opposite.

Who would pay, if not premiums

Medicare for All does not make health care free. It changes the collection method.

Today the bill is split among employer premiums (a hidden wage cut), worker premiums, deductibles, copays, Medicare payroll taxes and premiums, Medicaid taxes, and ACA subsidies. Under single payer, most of that stream is rerouted through the Treasury.

Financing sketches over the past decade have included some mix of:

• An employer payroll tax meant to replace what firms now spend on premiums

• An income-based premium or surtax on households

• Ending the tax exclusion for employer-sponsored insurance, which would raise income and payroll tax receipts as compensation shifted from benefits to wages

• Higher taxes on high earners, corporations, or capital income

• State maintenance-of-effort payments so Medicaid dollars do not vanish

• Deficit financing

The Committee for a Responsible Federal Budget estimated that covering a mid-range extra federal cost on the order of $30 trillion over ten years would take something like a 32 percent payroll tax, a 25 percent income surtax, a very large value-added tax, or a comparable package. Taxes on the wealthy alone do not close a gap that size. Sanders has proposed smaller specific rates—such as a 7.5 percent employer payroll tax and a 4 percent income-based premium—plus other offsets; independent scorekeepers have generally found those packages only partially cover comprehensive single-payer bills.

Two distributional facts sit underneath the fight. First, employer premiums are already a tax of sorts, just one that varies by firm and is invisible on a pay stub. Replacing them with a formal tax can be more progressive or less, depending on the rate schedule. Second, healthy workers with cheap employer plans can lose even if the national average household “saves,” because averages hide the people who currently consume little care.

The case for it

Supporters start from outcomes and overhead.

The United States spends about 17–18 percent of GDP on health care, far above the OECD average, with an uninsured population still in the tens of millions and high rates of skipped care because of cost. Life expectancy lags peer countries. Advocates argue that a single payer would finish the coverage job the ACA left incomplete, erase medical bankruptcy for covered services, and let doctors and hospitals deal with one claims system instead of hundreds. Traditional Medicare’s administrative costs are a small fraction of private insurers’. CBO’s single-payer work also assumed large cuts in payer overhead.

A national payer could set hospital and drug prices the way other rich countries do, rather than letting commercial rates float far above Medicare. That is the mechanism behind claims of national savings even while utilization rises. It is also why hospitals and pharmaceutical firms are the most concentrated opponents.

There is a labor-market argument as well. Job-lock—staying in a job for the insurance—would fade. Small firms would stop being insurance offices. Unions could bargain over wages and working conditions rather than plan design. Whether those gains outweigh the loss of employer-plan variety is a values question as much as an empirical one.

The case against it

Opponents start from disruption, supply, and politics.

Tens of millions of people say they like their current plan. A FabrizioWard battleground-district poll in 2026 found most privately insured respondents satisfied with existing coverage and a Republican advantage when a Democrat was described as replacing that coverage with a government system. Other national polls show majority support for a government plan. Both can be true: the abstract idea polls better than the concrete loss.

Provider rates are the other flashpoint. Commercial insurance pays hospitals and many specialists substantially more than Medicare. A system that paid Medicare rates at national scale would be a large revenue cut. Safety-net and rural hospitals that already run thin margins would be exposed first. If Congress raised rates to protect access, the federal price tag would climb and the savings case would shrink.

Innovation and wait times are the international talking points. Other single-payer or social-insurance countries spend less and cover everyone, and they also use waiting lists, technology budgets, and tighter limits on some high-cost care. The U.S. system is better at rapid access to specialists and new drugs for people who can pay. Whether that trade is acceptable depends on whether the problem you care about is the uninsured person or the insured person who wants the next therapy without delay.

Implementation risk is not theoretical. Vermont abandoned a state single-payer plan when the required tax rates became public. Colorado voters rejected ColoradoCare in 2016 by a wide margin, including in counties that voted Democratic. Federal law, ERISA, and the size of the employer market make a national version harder, not easier, even though only Washington can really do it.

What people think they are endorsing

Public opinion is real and contradictory.

Pew found in late 2025 that 66 percent of adults say the federal government has a responsibility to ensure coverage—but only 35 percent favor a single national government program, while 31 percent prefer a mix of private and public insurance. A Harvard-Harris battery in 2026 found 69 percent “for” a program called Medicare for All, while 57 percent said that under Medicare for All private insurers would still exist and you could get coverage from an employer. Jayapal’s PAC poll found 60 percent overall support and 94 percent among Democrats. An Economist/YouGov question that explicitly said private insurers would be eliminated still found 52 percent support. Republican-aligned battleground polling found the opposite when the replacement of current plans was emphasized.

The pattern is stable across a decade of KFF and other surveys: name the program after Medicare, and support is high; mention taxes and the end of employer insurance, and support drops. That is not evidence that the public is foolish. It is evidence that “Medicare” means “a program seniors like” to many voters, not “a ban on UnitedHealthcare.”

Politics, not just policy

Medicare for All has never had the votes of a governing majority. It remains a majority-of-the-House-Democratic-caucus project and a minority-of-the-Senate-Democratic-caucus project. Party leaders who want to win suburban districts often prefer a public option or ACA expansion—policies that poll with less baggage.

The 2026 environment has given the idea a second wind among progressives: marketplace premiums jumped after enhanced ACA subsidies expired, Medicaid rules tightened, and frustration with insurers and drug companies is high. That is a coverage-and-cost backlash, not yet a coalition that can pass a two-year transition to single payer over hospital, insurer, and employer opposition. Jayapal has said as much: without a trifecta, the work is to settle intra-party disagreements before 2029.

The choice the slogan conceals

Medicare for All is a coherent design. One payer. Broad benefits. Little or no point-of-service cost. Taxes instead of premiums. Private insurance reduced to extras. It would cover nearly everyone. It would rearrange a sixth of the economy. It would cut some prices by law and raise measured federal spending by trillions. It would make some families better off and some worse off, depending on their current plan and the tax used to replace it.

It is not a free upgrade of the Medicare card seniors already carry. It is not a public option you can ignore. It is not “what they have in Europe,” which is usually social insurance with private funds, cost-sharing, and global budgets rather than the Sanders-Jayapal specification.

The honest debate is therefore narrow and difficult: whether the gains in coverage, simplicity, and price leverage are worth the tax shift, the end of employer plans, and the risk that lower prices plus higher demand produce waiting rather than more care. Everything else is branding.